How Insurance Companies Turn Their Premiums Into Billions in Profit

Progressive generated $917 million of investment income from its float in Q1 2026, putting it on pace for nearly $3.7 billion annually versus about $3.58 billion in 2025. The article argues that float is a key profit engine for insurers like Berkshire Hathaway, Progressive, Markel, and Brookfield, but also highlights material downside risk if fixed-income or equity portfolios fall in value. Overall, the piece is a sector-level commentary on insurance investment income and volatility rather than a company-specific catalyst.

Analysis

The key market implication is not that insurers earn investment income, but that the value of float expands when the liability duration extends and reinvestment yields stay elevated. That favors the better-underwritten carriers with disciplined reserving and large, stable premium bases; in practice, the best operating leverage sits with firms that can compound float without needing aggressive equity risk to make the model work. Berkshire is the highest-beta expression of that thesis, while Progressive is the cleaner public-market version: less upside from portfolio convexity, but materially lower blow-up risk.

Second-order, higher rates are a mixed blessing. They boost near-term earnings on the float, but they also raise the discount rate on insurer portfolios and can expose latent reserve weakness if claims inflation re-accelerates. The bigger hidden risk is not market drawdown alone; it is a simultaneous deterioration in loss ratios and asset values, which can force insurers to choose between supporting underwriting growth and protecting capital. That dynamic is why the market should distinguish between firms with underwriting margin durability and those merely harvesting bond income.

The consensus is likely underestimating how much of the insurer re-rating has already happened through the rate cycle. If yields peak or drift lower, the incremental contribution from float income will decelerate even if it remains absolute positive; at that point, stock selection shifts back to underwriting quality and capital deployment discipline. Conversely, a sharp equity drawdown would likely create an entry window in names like BRK.B and PGR, because the long-duration compounding of float becomes more attractive precisely when near-term sentiment is weakest.

Key Decisions for Investors

• Buy BRK.B on a 5-10% market-driven pullback; target a 12-month hold. Risk/reward is favorable because float plus opportunistic capital deployment should compound through volatility, but trim if the market starts pricing a material equity drawdown into the portfolio.
• Stay long PGR as the cleaner float compounder, but size it smaller than BRK.B. Best entry is on any multiple compression tied to rate-sensitivity fears; downside is limited by underwriting discipline, while upside is steady compounding rather than multiple expansion.
• Pair trade: long PGR / short a higher-beta insurer with more portfolio-duration risk if available in the book. The thesis is that the market is overpaying for float income that depends more on asset appreciation than underwriting quality.
• Watch for a rates rollover over the next 3-6 months; if the 10-year yield trends down, reduce exposure to insurers whose valuation depends mainly on investment income and rotate toward those with stronger underwriting leverage.